PL2448590T3 - Medyczne węglowodany do leczenia stanów układu oddechowego - Google Patents

Medyczne węglowodany do leczenia stanów układu oddechowego

Info

Publication number
PL2448590T3
PL2448590T3 PL10793441T PL10793441T PL2448590T3 PL 2448590 T3 PL2448590 T3 PL 2448590T3 PL 10793441 T PL10793441 T PL 10793441T PL 10793441 T PL10793441 T PL 10793441T PL 2448590 T3 PL2448590 T3 PL 2448590T3
Authority
PL
Poland
Prior art keywords
carbohydrates
medicinal
treatment
respiratory conditions
respiratory
Prior art date
Application number
PL10793441T
Other languages
English (en)
Inventor
Betty Jin
Paul Arthur Jones
Ee Ling Seah
Wen Yang Wu
Peter James Jenkins
Original Assignee
Australian Biomedical Company Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009903123A external-priority patent/AU2009903123A0/en
Application filed by Australian Biomedical Company Pty Ltd filed Critical Australian Biomedical Company Pty Ltd
Publication of PL2448590T3 publication Critical patent/PL2448590T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL10793441T 2009-07-03 2010-07-02 Medyczne węglowodany do leczenia stanów układu oddechowego PL2448590T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2009903123A AU2009903123A0 (en) 2009-07-03 Carbohydrates
EP10793441.6A EP2448590B1 (en) 2009-07-03 2010-07-02 Medicinal carbohydrates for treatment of respiratory conditions
PCT/AU2010/000846 WO2011000053A1 (en) 2009-07-03 2010-07-02 Medicinal carbohydrates for treatment of respiratory conditions

Publications (1)

Publication Number Publication Date
PL2448590T3 true PL2448590T3 (pl) 2019-05-31

Family

ID=43410378

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10793441T PL2448590T3 (pl) 2009-07-03 2010-07-02 Medyczne węglowodany do leczenia stanów układu oddechowego

Country Status (19)

Country Link
US (2) US9040503B2 (pl)
EP (1) EP2448590B1 (pl)
JP (2) JP6057709B2 (pl)
KR (1) KR101843391B1 (pl)
CN (2) CN107126436B (pl)
AU (1) AU2010268689B2 (pl)
BR (1) BR112012000101B8 (pl)
CA (1) CA2766239C (pl)
DK (1) DK2448590T3 (pl)
ES (1) ES2709680T3 (pl)
IL (1) IL217185A (pl)
NZ (1) NZ597044A (pl)
PL (1) PL2448590T3 (pl)
PT (1) PT2448590T (pl)
RU (1) RU2539899C2 (pl)
SG (1) SG176732A1 (pl)
UA (1) UA110325C2 (pl)
WO (1) WO2011000053A1 (pl)
ZA (1) ZA201109040B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA110325C2 (en) * 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions
US11246878B2 (en) * 2013-03-15 2022-02-15 B&H Biotechnologies, Llc Compositions and products for infectious or inflammatory diseases or conditions
WO2014151526A1 (en) 2013-03-15 2014-09-25 Huiru Wang Biological therapeutics for infection-relating disorders or conditions
EP3261675A1 (en) 2015-02-25 2018-01-03 The U.S.A. as represented by the Secretary, Department of Health and Human Services Sialylation-increasing therapies for diseases associated with oxidative stress
CN109288114A (zh) * 2018-10-08 2019-02-01 厦门艾赛生物科技有限公司 一种唾液酸及其衍生物的应用和唾液酸电子烟液
CN117320728A (zh) * 2021-05-31 2023-12-29 王慧茹 唾液酸类似物或衍生物的应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6168418A (ja) * 1984-09-11 1986-04-08 Kanto Ishi Pharma Co Ltd 去痰薬
US5874261A (en) 1988-09-02 1999-02-23 The Trustees Of The University Of Pennsylvania Method for the purification of glycosyltransferases
CA1318592C (en) * 1988-11-18 1993-06-01 University Of British Columbia N-acetyl glucosamine as a cytoprotective agent
JPH02177891A (ja) * 1988-12-28 1990-07-10 Snow Brand Milk Prod Co Ltd 複合酵素反応によるシチジン‐5′‐モノホスフオシアル酸の合成方法
JPH03206050A (ja) 1989-12-29 1991-09-09 Mitsui Toatsu Chem Inc 医薬組成物
JP3206050B2 (ja) 1991-11-18 2001-09-04 住友電気工業株式会社 ダイヤモンド単結晶の合成方法
US5665561A (en) * 1994-06-06 1997-09-09 The Rockefeller University Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
WO1996002255A1 (fr) 1994-07-15 1996-02-01 Taiyo Kagaku Co., Ltd. Composition medicamenteuse contenant un derive d'acide sialique
JPH08337532A (ja) * 1995-06-14 1996-12-24 Takeda Chem Ind Ltd 医薬組成物
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
ATE258057T1 (de) * 1995-11-22 2004-02-15 Univ Montana State Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
EP0837511B1 (en) 1996-10-15 2005-09-14 Matsushita Electric Industrial Co., Ltd Solar cell and method for manufacturing the same
CN1067245C (zh) 1996-12-27 2001-06-20 中国人民解放军第三军医大学 N-乙酰-d-氨基葡萄糖在制备治疗呼吸道疾病的药物中的应用
JPH11206050A (ja) * 1998-01-16 1999-07-30 Mitsubishi Heavy Ind Ltd 磁石モータ
US6274568B1 (en) 1998-08-06 2001-08-14 Ronald L. Schnaar Compounds for altering cell surface sialic acids and methods of use therefor
JP2001131074A (ja) 1999-08-20 2001-05-15 Inst Of Physical & Chemical Res シアル酸誘導体を有効成分として含む医薬
US6492350B2 (en) 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
JP2002265365A (ja) * 2001-03-08 2002-09-18 Koyo Chemical Kk 好中球機能抑制剤
US20020182237A1 (en) * 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
WO2002101071A2 (en) 2001-06-07 2002-12-19 Rigel Pharmaceuticals, Inc. Cd43:modulators of mast cell degranulation
US20070259094A1 (en) 2002-10-21 2007-11-08 Willem Wassenaar N-acetylglucosamine as a food and beverage additive
TWI269656B (en) * 2003-03-05 2007-01-01 Original Image Co Ltd Therapeutical composition for hepatitis C
CN1533776A (zh) 2003-03-27 2004-10-06 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖在制备用于治疗病毒或细菌感染所致的局部损伤和全身症状的药物中的应用
US20060193824A1 (en) 2005-02-28 2006-08-31 Rubin Bruce K Methods for the treatment of infectious and inflammatory airway diseases
WO2006127977A1 (en) * 2005-05-24 2006-11-30 The Johns Hopkins University Fatty acid carbohydrate hybrid molecules as therapeutic agents and methods thereof
JP2008273919A (ja) 2007-05-07 2008-11-13 Lilac:Kk 組織・細胞障害のための予防・修復剤
WO2008150477A2 (en) * 2007-05-31 2008-12-11 Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health N-acetyl mannosamine as a therapeutic agent
US8916544B2 (en) * 2007-08-08 2014-12-23 The Johns Hopkins University Hybrid SCFA-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
US20090209488A1 (en) * 2008-02-19 2009-08-20 Roger Wayne Brown Compositions for the treatment of exercise induced asthma
UA110325C2 (en) * 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions

Also Published As

Publication number Publication date
BR112012000101B8 (pt) 2021-05-25
EP2448590A4 (en) 2013-05-15
US9040503B2 (en) 2015-05-26
ZA201109040B (en) 2013-02-27
IL217185A (en) 2015-03-31
CA2766239C (en) 2017-08-22
CN102665728A (zh) 2012-09-12
BR112012000101B1 (pt) 2021-02-23
US20150238512A1 (en) 2015-08-27
JP2016026170A (ja) 2016-02-12
BR112012000101A2 (pt) 2016-04-05
KR101843391B1 (ko) 2018-03-29
JP6057709B2 (ja) 2017-01-11
US20120142619A1 (en) 2012-06-07
EP2448590A1 (en) 2012-05-09
ES2709680T3 (es) 2019-04-17
WO2011000053A1 (en) 2011-01-06
JP2012531445A (ja) 2012-12-10
NZ597044A (en) 2013-08-30
PT2448590T (pt) 2018-12-06
RU2011150894A (ru) 2013-08-10
UA110325C2 (en) 2015-12-25
CA2766239A1 (en) 2011-01-06
KR20120050441A (ko) 2012-05-18
RU2539899C2 (ru) 2015-01-27
CN107126436A (zh) 2017-09-05
SG176732A1 (en) 2012-01-30
IL217185A0 (en) 2012-02-29
EP2448590B1 (en) 2018-10-31
DK2448590T3 (en) 2019-02-25
AU2010268689A1 (en) 2012-01-12
CN107126436B (zh) 2020-06-02
AU2010268689B2 (en) 2013-07-18
US10195226B2 (en) 2019-02-05

Similar Documents

Publication Publication Date Title
IL259475A (en) Combined therapy for the treatment of diabetes
EP2282795A4 (en) TREATMENT OF RESPIRATORY DISEASES
IL219073A (en) A drug combination for cancer treatment
EP2448622A4 (en) NEBULIZER FOR INFANTS AND PATIENTS WITH RESPIRATORY PROBLEMS
EP2557921A4 (en) METHOD FOR TREATING RESPIRATORY BREATHING DURING SLEEPING
ZA201205829B (en) Treatment of respiratory disorders
EP2332459A4 (en) MEDICAL TREATMENT SYSTEM
HK1169804A1 (zh) 治療疼痛的方法
AU339607S (en) Medical device for treatment of sleep disorders
GB0915515D0 (en) Treatment of vasculoproliferative conditions
GB0908193D0 (en) Treatment of disease state
IL206491A0 (en) Treatment of produce
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
EP2638389A4 (en) TREATMENT OF EXTRACTION OF RENEWAL
IL217185A0 (en) Medicinal carbohydrates for treatment of respiratory conditions
ZA201207696B (en) Compound for treatment of respiratory condition or disease
IL215854A0 (en) Pharmaceutical compositions for the treatment of nasal polyposis
TWM390783U (en) Improved structure of push bed for medical treatment
GB201001912D0 (en) Treatment of respiratory disorders
GB0901832D0 (en) Respiratory disease treatment
GB0901831D0 (en) Respiratory disease treatment
GB0910944D0 (en) Respiratory disease treatment
GB0908666D0 (en) Treatment of proteostatic disease
GB0913427D0 (en) Compounds for treatment of imflammation
HUP0900504A2 (en) Cream for treatment of skin-irritation